|

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

RECRUITINGSponsored by Imelda Hospital, Bonheiden
Actively Recruiting
SponsorImelda Hospital, Bonheiden
Started2022-02-11
Est. completion2028-12-31
Eligibility
Age55 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05246813

Summary

Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.

Eligibility

Age: 55 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 65 years and older

Exclusion Criteria:

* known haematological condition (myelodysplasia, leukemia, cancer)
* inability to provide written informed consent

Conditions6

AgingArthritisClonal Hematopoiesis of Indeterminate PotentialHip FracturesOsteoarthritis, HipOsteoporosis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.